000 01277 a2200361 4500
005 20250516125700.0
264 0 _c20131223
008 201312s 0 0 eng d
022 _a1538-8514
024 7 _a10.1158/1535-7163.MCT-12-0508
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDeGraff, David J
245 0 0 _aCurrent preclinical models for the advancement of translational bladder cancer research.
_h[electronic resource]
260 _bMolecular cancer therapeutics
_cFeb 2013
300 _a121-30 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aDisease Models, Animal
650 0 4 _aHumans
650 0 4 _aTranslational Research, Biomedical
650 0 4 _aUrinary Bladder Neoplasms
_xpathology
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aRobinson, Victoria L
700 1 _aShah, Jay B
700 1 _aBrandt, William D
700 1 _aSonpavde, Guru
700 1 _aKang, Yibin
700 1 _aLiebert, Monica
700 1 _aWu, Xue-Ru
700 1 _aTaylor, John A
773 0 _tMolecular cancer therapeutics
_gvol. 12
_gno. 2
_gp. 121-30
856 4 0 _uhttps://doi.org/10.1158/1535-7163.MCT-12-0508
_zAvailable from publisher's website
999 _c22373695
_d22373695